Live Breaking News & Updates on Biopharma Corporation

Stay updated with breaking news from Biopharma corporation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Arbutus Biopharma Co. (NASDAQ:ABUS) Shares Sold by FourWorld Capital Management LLC

FourWorld Capital Management LLC lessened its stake in Arbutus Biopharma Co. (NASDAQ:ABUS – Free Report) by 18.7% in the 4th quarter, Holdings Channel.com reports. The fund owned 1,090,851 shares of the biopharmaceutical company’s stock after selling 251,056 shares during the quarter. Arbutus Biopharma comprises approximately 1.8% of FourWorld Capital Management LLC’s investment portfolio, making the […] ....

United States , Arbutus Biopharma Co , Holdings Channel , Barclays Plc , Arbutus Biopharma Corporation , Sg Americas Securities , Fourworld Capital Management , Path Wealth Partners , China Universal Asset Management Co , Arbutus Biopharma , Free Report , World Capital Management , Universal Asset Management , Chardan Capital , Get Free Report , Biopharma Corporation , Visit Holdingschannel , Arbutus Biopharma Daily ,

FourWorld Capital Management LLC Sells 251,056 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS)

FourWorld Capital Management LLC reduced its position in shares of Arbutus Biopharma Co. (NASDAQ:ABUS – Free Report) by 18.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,090,851 shares of the biopharmaceutical company’s stock after selling 251,056 shares during the quarter. Arbutus Biopharma […] ....

United States , Path Wealth Partners , China Universal Asset Management Co , Arbutus Biopharma Company Profile , Arbutus Biopharma Co , Barclays Plc , Arbutus Biopharma Corporation , Sg Americas Securities , Fourworld Capital Management , Arbutus Biopharma , Free Report , World Capital Management , Universal Asset Management , Get Free Report , Biopharma Corporation , Arbutus Biopharma Daily ,

Arbutus to Participate in Jefferies Global Healthcare Conference

29.05.2024 - WARMINSTER, Pa., May 29, 2024 (GLOBE NEWSWIRE) - Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B . ....

Lisam Caperelli , Arbutus Biopharma Corporation Nasdaq , Biopharma Corporation ,

Arbutus to Participate in Two Upcoming Investor Conferences

Arbutus to Participate in Two Upcoming Investor Conferences
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Lisam Caperelli , Arbutus Biopharma Corporation Nasdaq , Biopharma Corporation ,